The WACC of Nuvo Pharmaceuticals Inc (MRV.TO) is 5.5%.
| Range | Selected | |
| Cost of equity | 5.30% - 9.90% | 7.60% |
| Tax rate | 2.10% - 5.70% | 3.90% |
| Cost of debt | 5.40% - 5.40% | 5.40% |
| WACC | 5.3% - 5.7% | 5.5% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.42 | 0.95 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.30% | 9.90% |
| Tax rate | 2.10% | 5.70% |
| Debt/Equity ratio | 6.33 | 6.33 |
| Cost of debt | 5.40% | 5.40% |
| After-tax WACC | 5.3% | 5.7% |
| Selected WACC | 5.5% | |